E-ISSN:2456-3110

Research Article

Antipyretic activity

Journal of Ayurveda and Integrated Medical Sciences

2022 Volume 7 Number 1 Jan-Feb
Publisherwww.maharshicharaka.in

An in vivo study to evaluate the antipyretic activity of Suryaprabha Gulika in brewer’s yeast induced pyrexia in wistar albino rats

Veena G.1*, Mohanan A.2, Bhat S.3, Ramesh N.4
DOI: http://dx.doi.org/10.21760/jaims.7.1.11

1* G Veena, Post Graduate Scholar, Department of Rasashastra and Bhaishajya Kalpana (Medicinal Chemistry and Pharmacy), Amrita School of Ayurveda, Amrita School of Ayurveda, Kerala, India.

2 Arun Mohanan, Associate Professor, Department of Rasashastra and Bhaishajya Kalpana (Medicinal Chemistry and Pharmacy), Amrita School of Ayurveda, Amrita Vishwa Vidyapeetham, Kerala, India.

3 Sudhakar Bhat, Research officer, Department of Pharmacology, SDM Centre for Research in Ayurveda and Allied Sciences, Udupi, Karnataka, India.

4 NV Ramesh, Professor and HOD, Department of Rasasastra and Bhaishajya Kalpana (Medicinal Chemistry and Pharmacy), Amrita School of Ayurveda, Amrita Vishwa Vidyapeetham, Kerala, India.

Introduction: Suryaprabha Gulika is one of the Rasayoga, mentioned in Sahasrayogam Gulika Prakarana, prepared by Khalviya method of preparation. The formulation is widely practiced clinically and prescribed in conditions of fever associated with Svasa and Kasa. In the present scenario, validation of any classical concept has emerged to be essential for acceptance by the scientific community. Since antipyretic activity could be elicited in animal models, the present study aims at eliciting the antipyretic activity of Suryaprabha Gulika in wistar albino rats using brewer’s yeast induced pyrexia method. Materials and methods: Suryaprabha Gulika was prepared as per the classical reference text, Sahasrayogam. Qualitative and quantitative assessment of the prepared drug was carried out. The experimental study to evaluate the antipyretic activity of the formulation was screened using brewer’s yeast induced pyrexia method. Statistical test used for evaluation was one way ANOVA followed by Dunett’s multiple comparison ‘t’ test as post- Hoc test, if p<0.05 was considered significant, using graphpad instat software. Results: When compared to the control group, Suryaprabha Gulika was found to be effective in bringing about antipyretic action. It also had almost similar efficacy as that of standard drug in bringing about antipyretic action in experimental models. Discussion: The antipyretic study of Suryaprabha Gulika in wistar albino rats brought out that the drug possesses highly significant antipyretic action.

Keywords: Ayurveda, Antipyretic, Sahasrayogam, Suryaprabha Gulika, Wistar albino rats

Corresponding Author How to Cite this Article To Browse
G Veena, Post Graduate Scholar, Department of Rasashastra and Bhaishajya Kalpana (Medicinal Chemistry and Pharmacy), Amrita School of Ayurveda, Amrita School of Ayurveda, Kerala, , India.
Email:
G Veena, Arun Mohanan, Sudhakar Bhat, NV Ramesh, An in vivo study to evaluate the antipyretic activity of Suryaprabha Gulika in brewer’s yeast induced pyrexia in wistar albino rats. J Ayu Int Med Sci. 2022;7(1):76-88.
Available From
https://jaims.in/jaims/article/view/1657

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2022-01-29 2022-01-31 2022-02-07 2022-02-14 2022-02-20
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
Nil Nil Yes 18%

© 2022by G Veena, Arun Mohanan, Sudhakar Bhat, NV Rameshand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Introduction

Suryaprabha Gulika is a herbomineral formulation having reference in Sahasrayogam, Gulika Prakarana.

The formulation consists of 11 ingredients, out of which two are of minerals (Parada and Gandhaka in the form of Kajjali) and 9 herbal ingredients (Ramatha, Triphala, Trikatu, Yavani and Vatsanabha) and the media for trituration is Jambira Svarasa.

The formulation is indicated in Sula, Kasa, Svasa and Mahajvara.[1] Even though Suryaprabhā Gulika is widely practiced clinically and prescribed in conditions of fever, associated with Svasa and Kasa, the action of the drug remained unexplored.

The objective of pharmacological study is to provide a scientific foundation for better therapeutics and in the Ayurvedic context, to reassess the efficacy of the Ayurvedic drugs or to standardize drug dose.

Many formulations are going out of practice gradually because their role, importance, and efficacy are not scientifically documented. In this present scientific era, it is necessary to carry out the animal experimental studies, as it re-validate the efficacy of Ayurvedic drugs in living organisms.

Pyrexia is a state when the body temperature tends to rise above the normal range.

Fever is a condition wherein pyrexia can be generally observed. Since antipyretic activity could be elicited in animal models, the present study aims at eliciting the antipyretic activity of Suryaprabha Gulika in wistar albino rats using brewer’s yeast induced pyrexia method.

Thus, the study aims at a scientific validation of the antipyretic action of the formulation in experimental models.

Aims and Objectives

  1. To analyze the physicochemical properties of Suryaprabha Gulika.
  2. To experimentally evaluate the antipyretic activity of Suryaprabha Gulika in wistar albino rats.

Materials and Methods

  1. Preparation of Suryaprabha Gulika

Table 1: Ingredients of Suryaprabha Gulika.

SN Ingredients Quantity
1. Sodhita Parada 1 part
2. Sodhita Gandhaka 1 part
3. Ramatha 1 part
4. Triphala (Haritaki, Vibhitaki, Amalaki) 1 part
5. Trikatu (Pippali, Marica, Sunthi) 1 part
6. Yavani 1 part
7. Suddha Vatsanabha 1/16th part of above ingredients
8. Jambira Svarasa Q. S for trituration.

Method of preparation: Kajjali was prepared using Sodhita Parada and Sodhita Gandhaka (1 part each), by means of trituration in the Khalva Yantra. The powder of all the herbal ingredients was added one by one, according to the formulation, into the prepared Kajjali. Sodhita Vatsanabha was added in the quantity of 1/ 16th part of the total ingredients. The trituration of the ingredients was done along with Jambira Svarasa for 12 hours. When the mixture was properly ground, pills with the size of one Gunja (125 mg) was rolled out.

Dose: 125 mg.

Indications:  Sula, Kasa, Svasa and Mahajvara.

  1. Assessing the analytical parameters: Physicochemical analysis of Suryaprabha Gulika was carried out.

(a) Organoleptic characters: These includes assessing the colour, odour, state, and taste of the drug. By assessing the organoleptic characters, the basic information of the drug can be identified. The specific characters of a drug, which can be identified by using sense organs are included under this test. The quality of the drug can be inferred up to some extent, with this assessment.

(b) Physicochemical parameters: The physicochemical parameters assessed were: Weight variation test, Friability test, Hardness test, pH (5% solution), Disintegration test, LOD at 110C, Ash value, Acid insoluble ash, Water soluble ash, Alcohol soluble extractive and Water soluble extractive.[2]


  1. Experimental Study (In Vivo): The study was carried out after obtaining the permission of IAEC. Approval number-SDMCRA/IAEC/AM-R-02 (7-1-2019)

In this study, the antipyretic activity of Suryaprabha Gulika was assessed in wistar albino rats by using brewer’s yeast induced pyrexia method.


Drugs used

  1. Test drug: Suryaprabha Gulika
  2. Distilled water
  3. Brewer’s yeast solution
  4. CarboxyMethylCellulose (CMC)
  5. Standard drug: Paracetamol IP tablets (Dolo 650)

Equipments used

  1. Digital tele thermometer
  2. Glass beaker and stirrer
  3. Disposable syringes
  4. Weighing balance
  5. Hand gloves

Preparation of the drug

  1. Preparation of 15% brewer’s yeast solution: Brewer’s yeast was procured from the local market (New Diana Stores, Udupi). 4.5g of yeast + 30ml saline was taken in a small beaker, properly mixed, covered with an aluminium foil and kept in the incubator at 37°C for 40 hours for fermentation.
  2. Test drug (Suryaprabha Gulika): 22.5 mg drug +100 mg CarboxyMethylCellulose + 20 ml distilled water.
  3. Standard drug (Paracetamol IP tablets (Dolo 650) manufactured by Micro labs limited): 200mg drug + 100mg CarboxyMethylCellulose + 20 ml distilled water.
  4. Control drug: 100mg CarboxyMethylCellulose + 20 ml distilled water.

Experimental animals

  • Wistar strain albino rats were selected from Animal house of SDM Center for Research in Ayurveda and Allied sciences, Udupi.
  • The rats were maintained under strict laboratory conditions of controlled environment, temperature, humidity, light and dark cycles.
  • Rats were fed with pellets purchased from Sai Durga stores, Bangalore, India and water ad libitum

Inclusion criteria

  • Healthy albino rats of either sex were included in the study.
  • Weighing about 150g-250g.

Exclusion criteria

  • Less than 150g and more than 250g.
  • Pregnant and diseased rats.
  • Rats, which are under trail of other experiments.

Numbering and identification: Animals were marked with saturated picric acid solution in water for proper identification.

Table 2: Grouping of experimental animals.

Group Number of animals Drug Dose
Control 6 Distilled water + CMC* 10ml/kg body weight
Standard 6 Paracetamol + Distilled water + CMC 100mg/kg body weight
Test 6 Suryaprabha Gulika + Distilled water + CMC 11.25mg/kg body weight

* CMC - CarboxyMethylCellulose

Routes of administration

  • Yeast solution was injected through subcutaneous route.
  • Test/Standard/Control group drugs were administered through oral route by using rat feeding tube.

Dose fixation

Referring to the table of Paget & Barner’s, dose of test drug for the rats were calculated based on the conversion formula:

Human dose × Body surface area ratio convertible factor

Human dose × Surface area factor (0.018) × 5/kg body weight

Rat dose = Human dose × 0.018/200g body weight

Therefore, dosage of

(a) Test drug (Suryaprabha Gulika) was

  = 125mg ×0.018×5/ kg body weight

  = 11.25 mg/kg body weight

(Human dose of Suryaprabha Gulika is taken here as 125mg)

(b) Standard drug (Paracetamol IP tablets (Dolo 650)) = 100mg/kg body weight

(c) Control drug: 10mg/kg body weight


(d) Yeast injection dose: 10mg/kg body weight

Experimental design

  • Initial rectal temperature of the animals was recorded.
  • Pyrexia was induced by subcutaneous injection of 15% yeast solution in normal saline solution.
  • The room temperature was kept at 22–24°C.
  • Immediately after yeast administration, food was withdrawn.
  • After 18 hours, rectal temperatures were recorded using digital tele thermometer.
  • Only those animals in which the rectal temperature raised from 0.5 to 2°C, after the yeast injection were taken to the study.
  • The drug (test/standard/control) were administered via oral route through the rat feeding tube.
  • The rectal temperature was recorded by using digital tele thermometer for consecutive 1st, 2nd, 3rd, 4th, 5th and 24th hours post dosing.

Evaluation: The basal temperature, rectal temperature 18 hour after induction of pyrexia, and hourly temperature (for 1st, 2nd, 3rd, 4th, 5th, and 24th hours) were recorded using digital tele thermometer for all the three groups. The differences between the temperature values at each time interval were recorded against initial temperature of the same group and compared. The maximum reduction in rectal temperature in the test and standard group, in comparison to the control group was calculated. Further, the results of the test group was compared with the values of standard group.

Statistical Analysis: One way ANOVA followed by Dunett’s multiple comparison ‘t’ test as post- Hoc test, if p<0.05 was found significant, using graphpad instat software.

Observations and Results

  1. Assessment of Analytical parameters

Table 3: Organoleptic characters of Suryaprabha Gulika.

SN  Parameters Observation
1. Colour Black
2. Odour Characteristic of Hingu
3. State Solid (round balls of 3 to 4 mm diameter)
4. Taste Characteristic of its ingredients

Table 4: Physicochemical characters of Suryaprabha Gulika.


SN Parameters Observations
1. pH (5% solution) 2.93 at 28.5°C
2. LOD at 110°C 9.93%
3. Total Ash 6.12% w/w
4. Acid insoluble ash 0.824% w/w
5. Water soluble ash 4.46% w/w
6. Alcohol soluble extractive 12.116%
7. Water soluble extractive 25.88%
8. Hardness test 2 kg/cm2
9. Friability test 0.14%
10. Weight variation Passes the weight variation test. (within the acceptable range of ±7.5% weight variation)
11. Disintegration test
(a) In water 6 hours
(a) In acid medium 6 hours

  1. Experimental Study (In Vivo)

Initially, normal body temperature of all rats on an average was recorded. After the administration of the brewer’s yeast, all the animals were observed for their behaviour changes. All the symptoms as mentioned below confirmed that the rats were suffering from fever:

  • Temperature of all albino rats increased.
  • Trembling is noted after 1 hour of brewer’s yeast injection.
  • Fur erected.
  • Face of all animals bent down.

Observations and results of the study, to evaluate the antipyretic activity of Suryaprabha Gulika, are given below in the following tables:

Data expressed in MEAN±SEM, *P<0.05, **P<0.01 in comparison to rectal (°C)18 hours after yeast induced pyrexia.

Brewer’s yeast injection has shown increased rectal temperature of all the groups i.e., control, standard, test drug groups and was found to be statistically


significant while comparing to their basal rectal temperature.

Table 5: Effect of Suryaprabha Gulika on brewer’s yeast induced pyrexia in wistar albino rats within the groups.


Group Basal temperature (°C) Rectal temperature (°C) 18hr after yeast induced pyrexia Rectal temperature measured at the different time intervals
1st 2nd 3rd 4th 5th 24th
Control 37.75± 0.23 38.51± 0.10** 38.6± 0.10 38.73± 0.14 38.81± 0.11 38.66± 0.10 38.41± 0.12 38.36± 0.14
Standard 37.53± 0.08 37.96± 0.08* 37.75± 0.11 37.2± 0.10** 37.33± 0.10** 38.01± 0.12 38.93± 0.04** 37.61± 0.12
Test 37.71± 0.15 38.35± 0.11** 38.22± 0.10 38.07± 0.12 37.84± 0.06** 38± 0.08 37.82± 0.10** 37.77± 0.10**

Data shows there was increase in rectal temperature of control group at 1st h, 2nd h, 3rd h, 4th hour and decrease at 5th h and 24th hour when compared to the basal temperature of same group, the observed data was found to be non-significant.

Data shows there was non-significant increase in rectal temperature of reference standard group at 4th hour and a very significant increase at 5th hour and a non-significant decrease at 1st and 24th hour and a very significant decrease at 2nd and 3rd hour when compared to the basal temperature of same group.

Data shows there was a non-significant decrease in rectal temperature of test group at 1st h, 2nd h and 4th hour and a very significant decrease at 3rd h, 5th h and 24th hour when compared to the basal temperature of same group.

Table 6: Effect of Suryaprabha Gulika during 1st hour of temperature.


Group 1st hour % change
Control 38.6±0.10 --
Standard 37.75±0.11** 2.20↓
Test 38.22±0.10 0.98↓

Data: MEAN ± SEM **p<0.01

Graph 1: Effect of Suryaprabha Gulika during 1st hour of temperature.

jaims_1657_.01.JPG

  • The data shows that there was decrease in body temperature after first hour of Suryaprabha Gulika, when compared to the control group, the observed decrease was found to be statistically non-significant.
  • The data shows there was decrease in body temperature after 1 hour of reference standard group, when compared to the control group, the observed decrease was found to be statistically very significant.

Table 7: Effect of Suryaprabha Gulika during 2nd hour of temperature.

Group 2nd hour % change
Control 38.73±0.14 --
Standard 37.2±0.10** 3.95↓
Test 38.07±0.12** 1.70↓

Data: MEAN ± SEM **p<0.01


  • The data shows that there was decrease in body temperature after 2nd hour of reference standard when compared to the control group, the observed decrease was found to be statistically very significant.
  • The data shows that there was decrease in body temperature after 2nd hour of Suryaprabha Gulika when compared to the control group, the observed decrease was found to be statistically very significant.

Graph 2: Effect of Suryaprabha Gulika during 2nd hour of temperature.

jaims_1657_.02.JPG

Graph 3: Effect of Suryaprabha Gulika during 3rd hour of temperature.

jaims_1657_.03.JPG

Table 8: Effect of Suryaprabha Gulika during 3rd hour of temperature.

Group 3rd hour % change
Control 38.81±0.11 --
Standard 37.33±0.10** 3.81↓
Test 37.84±0.06** 2.49↓

Data: MEAN ± SEM **p<0.01

  • The data shows that there was decrease in body temperature after 3rd hour of reference standard when compared to the control group, the observed decrease was found to be statistically very significant.
  • The data shows that there was decrease in body temperature after 3rd hour of Suryaprabha Gulika when compared to the control group, the observed decrease was found to be statistically very significant.

Table 9: Effect of Suryaprabha Gulika during 4th hour of temperature

Group 4th hour % change
Control 38.66±0.10 --
Standard 38.01±0.12** 1.68↓
Test 38±0.08** 1.70↓

Data: MEAN ± SEM **p<0.01

Graph 4: Effect of Suryaprabha Gulika during 4th hour of temperature.

jaims_1657_.04.JPG

  • The data shows that there was decrease in body temperature after 4th hour of reference standard, when compared to the control group, the observed decrease was found to be statistically very significant.
  • The data shows that there was decrease in body temperature after 4th hour of Suryaprabha Gulika when compared to the control

  • group, the observed decrease was found to be statistically very significant.

Table 10: Effect of Suryaprabha Gulika during 5th hour of temperature.

Group 5th hour % change
Control 38.41±0.12 --
Standard 38.93±0.04** 1.35↑
Test 37.82±0.10** 1.53↓

Data: MEAN ± SEM **p<0.01

Graph 5: Effect of Suryaprabha Gulika during 5th hour of temperature.

jaims_1657_.05.JPG


  • The data shows that there was increase in body temperature after 5th hour of reference standard when compared to the control group, the observed increase was found to be statistically very significant.
  • The data shows that there was decrease in body temperature after 5th hour of Suryaprabha Gulika when compared to the control group, the observed decrease was found to be statistically very significant.

Table 11: Effect of Suryaprabha Gulika during 24th hour of temperature.


Group 24th hour % change
Control 38.36±0.14 --
Standard 37.61±0.12** 1.95↓
Test 37.77±0.10** 1.53↓

Data: MEAN ± SEM **p<0.01

Graph 6: Effect of Suryaprabha Gulika during 24th hour of temperature.


jaims_1657_.06.JPG


  • The data shows that there was decrease in body temperature after 24th hour of reference standard, when compared to the control group, the observed decrease was found to be statistically very significant.
  • The data shows that there was decrease in body temperature after 24th hour of Suryaprabha Gulika when compared to the control group, the observed decrease was found to be statistically very significant.

Graph 7: Showing the antipyretic effect of control, standard and test group.


jaims_1657_.07.JPG



Discussion

Discussion about the antipyretic study

The antipyretic study was screened by using brewer’s yeast induced pyrexia method.

Effect of Suryaprabha Gulika on brewer’s yeast induced pyrexia in wistar albino rats within the groups:

Brewer’s yeast injection has shown increased rectal temperature of all the groups i.e., control, standard, test drug groups and was found to be statistically significant while comparing to their basal rectal temperature.

Table 12: Hourly observations and statistical significance.


Hour Group Observation Statistical significance, when compared to control group
1st hour   Test group Decrease in temperature Non-significant
Standard group Decrease in temperature Very significant
2nd hour Test group Decrease in temperature Very significant
Standard group Decrease in temperature Very significant
3rd hour Test group Decrease in temperature Very significant
Standard group Decrease in temperature Very significant
4th hour Test group Decrease in temperature Very significant
Standard group Decrease in temperature Very significant
5th hour Test group Decrease in temperature Very significant
Standard group Increase in temperature Very significant
24th hour Test group Decrease in temperature Very significant
Standard group Decrease in temperature Very significant

In control group, when compared to the basal temperature of same group, the following was observed:


  • Non-significant increase in rectal temperature at 1st hr, 2nd hr, 3rd hr, 4th
  • Non-significant decrease in rectal temperature at 5th hr and 24th

In standard group, when compared to the basal temperature of same group the following was observed:


  • Non-significant increase in rectal temperature at 4th
  • Very significant increase in rectal temperature at 5th
  • Non-significant decrease in rectal temperature at 1st and 24th
  • Very significant decrease in rectal temperature at 2nd and 3rd

In test group, when compared to the basal temperature of same group the following was observed:


  • Non-significant decrease in rectal temperature at 1st hr, 2nd hr and 4th
  • Very significant decrease at 3rd hr, 5th hr and 24th

Discussion about the drug

Suryaprabha Gulika is classical herbomineral preparation prescribed for generalized fever and the use is well established in Ayurvedic practice.

The present study is mainly focused on the Antipyretic effect of Suryaprabha Gulika.

In this study, the pyrexia was induced by 15% brewer’s yeast in the dose of 10ml/kg body weight dose and the rats with rectal temperature above the basal temperature i.e., 37°C were recruited for the study.
The pyrexia was achieved after 18h after yeast injection. Thereafter, the rectal temperature was measured repeatedly at an interval of 1st, 2nd, 3rd, 4th, 5th and 24th hours.

The data showed that in the control group, there was non-significant decrease in the rectal temperature throughout the experimental reading.

The standard drug (Paracetamol) administered rats showed remarkable reduction in the rectal temperature during 2nd and 3rd hours reading and it was found to be statistically significant.

The analysis of the results obtained clearly indicates


that the test group drug (Suryaprabha Gulika) has significant antipyretic activity. When compared with control group, Suryaprabha Gulika has remarkable antipyretic activity profile.

Comparing to fever temperature produced after 18 hours of yeast administration, Suryaprabha Gulika showed more significant reduction in temperature in hourly observation of temperature.

Antipyretic drugs usually make the hypothalamus to override a prostaglandin-induced increase in temperature. Then the body works to lower the temperature and results in reduction in fever.  That is, by preventing the PGE2 synthesis, the antipyretic drugs act by blocking the COX-2 enzymes and thereby decrease the body temperature.[3]

The study provides evidence for the presence of antipyretic activity in Suryaprabha Gulika.  It would be interesting to ascertain the probable mechanism of action which may be due to either interference in the production of heat leading to pyrexia or it may be due to enhanced dissipation of the temperature by the drug.

The antipyretic activity may be exhibited due of the presence of secondary metabolites present within the herbal ingredients of the formulation. It is supposed that COX-2 inhibitors from natural sources possess comparatively less side effects than the synthetic drugs which produces toxic effects on different organs of the body.

Probable mode of action of the drug- Ayurvedic perspective

Suryaprabha Gulika is a Khalviya Rasayana that contains two mineral ingredients (Parada and Gandhaka in the Kajjali form) and nine herbal ingredients (Ramatha, Triphala, Trikatu, Yavani, Vatsanabha), triturated in the media of Jambira Svarasa.

Jvara is a pathological condition which manifests due to Vikrita Pitta, Ama and Agnimandhya. Agni is impaired in Jvara, which in turn vitiates the Rasa Dhatu. Obstruction of the Srotas is resulted by this impaired Rasa dhatu, which circulate all over the Sarira.

The Jvaraghna Karma, not only includes Santapa Samana, but also involves in Dipana, Pacana, Sroto Sodhana, Pitta Samana, Svedana, and Krimighna actions.

Table 13: Rasapanchaka of ingredients of Suryaprabha Gulika.

SN Drugs Rasa Guna Virya Vipaka Karma
1. Ramatha Katu Tikshna Usna   Katu AnulomanaDipana, Hridya, Krimighna, Pacana, Rucya, Vatakaphaprasamana
2. Haritaki Madhura, Amla, Katu, Tikta, Kashaya Laghu, Ruksha   Usna   Madhura   Caksusya, Dipana, Hridya, Medhya, Sarvadosaprasamana, Rasayana, Anulomana
3. Vibhitaki Kashaya   Laghu, Ruksha   Usna   Madhura Caksusya, Kesya, Kaphapittajit, Bhedaka, Kriminasana, Kasahara
4. Amalaki Madhura, Amla, Katu, Tikta, Kashaya Laghu, Ruksha   Sita   Madhura Caksusya, Rasayana, Tridoshajit, Vrishya
5. Pippali Madhura, Katu, Tikta Laghu, Snigdha   Anusna   Madhura Dipana, Hridya, Rasayana, Rucya, Vrishya, Recana, Tridosahara, Vatahara
6. Marica Katu, Tikta   Laghu, Ruksha Usna   Katu Dipana, Sleshmahara, Rucya, Pittakara, Vatahara, Kaphavatajit, MedhoharaJantunashana
7. Sunthi Katu   Laghu, Snigdha   Usna   Madhura Dipana, Hridya, AnulomanaPacana, Vatakaphapaha, Asmadosahara
8. Yavani Katu, Tikta     Laghu, Ruksha, Tikshna Usna   Katu Dipana, Pacana, Rucya, Krimighna, Sulahara, Anulomana
9. Vatsanabha Madhura     Vikashi, Vyavayi, Yogavahi, Laghu, Ruksha, Usna, Tikshna  Usna Madhura Rasayana, Pittasantapakaraka, Tridoshahara

Moreover, Vatsanabha brings about dilatation of the Svedavaha Srotas as it possesses diaphoretic action and also enhance the Jvaraghna action by its Vyavayi property. Probably, the antipyretic action exhibited by Vatsanabha may be due to its influence on the circulation and respiration and of its diaphoretic action.[4] Trikatu present in the formulation does the Dipana action. Triphala shows Rasayana effect and the Kostasodhana is done by the Ramatha. Dipana and Pacana action are exhibited by Yavani. Kajjali has the property of exhibiting effective action even at the lower doses, which may be attributed by its Yogavahi property. It acts as a carrier and enhance the action of the drug, by increasing the potency


of even small quantity of herbal ingredients present in the formulation. Bhavana with Jambira Svarasa further potentiates the formulation with the Dipana, Pacana and Rocana Gunas of Jambira.  In classical literatures, the inter relation between Usna Guna and Pitta Dosha is clearly stated. Most of the drugs in the formulation possess Pitta Samana property and hence helps to reduce the Usnatva Guna of Jvara. It can be inferred that all drugs in Suryaprabha Gulika possess Jvaraghna property.

jaims_1657_.8.JPGFigure 1: Brewer’s yeast.

jaims_1657_.9.JPGFigure 2: Preparation of 15% brewer’s yeast solution.

jaims_1657_.10.JPGFigure 3: 15% brewer’s yeast solution after fermentation.

jaims_1657_.11.JPGFigure 4: Preparation of drug into suspension form.


jaims_1657_.12.JPGFigure 5: Grouping of animals.


jaims_1657_.13.JPGFigure 6: Subcutaneous yeast injection.


jaims_1657_.14.JPGFigure 7: Rat showing symptoms of fever.

jaims_1657_.15.JPGFigure 8: Administration of drug through rat feeding tube.

jaims_1657_.16.JPGFigure 9: Recording the rectal temperature of the animal.




Conclusion

Antipyretic activity of Suryaprabha Gulika was assessed in wistar albino rats by using brewer’s yeast induced pyrexia method. When compared to the control group, the test drug was found to be effective in bringing about antipyretic action. Test drug had almost similar efficacy as that of standard drug in bringing about antipyretic action in experimental models.

Reference

  1. V Krishnan Vaidhyan & S. Gopala Pillai. Gulika Prakaranam. Sahasrayogam. Alappuzha: Vidhyarambham publications; 2016.p.153-154.
  2. Ministry of AYUSH. The Ayurvedic pharmacopoeia of India. 1st ed. Ghaziabad: Pharmacopoeia Commission for Indian Medicine & Homeopathy; 2016.
  3. Geetha N. Textbook of Medical Physiology. 2nd ed. Hyderabad: Paras Medical Publisher; 2011.
  4. Sud S, Sud KS. Efficacy and Usefulness of Visha dravyas in Rasaushadhis (HMPs). J Tradit Med Clin Natur. 2018 Feb 23; 7(1): 267 Available from: https://www.omicsonline.org/open-access/efficacy-and-usefulness-of-visha-dravyas-in-rasaushadhis-hmps-2573-4555-1000267-98798.html. DOI:10.4172/2573-4555.1000267.